2023-11-302024-11-292024-11-29false13736366222 HEALTHCARE SERVICES LIMITED2025-08-27falseiso4217:GBPxbrli:pure137363662023-11-29137363662024-11-29137363662023-11-302024-11-29137363662022-11-29137363662023-11-29137363662022-11-302023-11-2913736366bus:SmallEntities2023-11-302024-11-2913736366bus:AuditExempt-NoAccountantsReport2023-11-302024-11-2913736366bus:FullAccounts2023-11-302024-11-2913736366bus:PrivateLimitedCompanyLtd2023-11-302024-11-2913736366core:WithinOneYear2024-11-2913736366core:AfterOneYear2024-11-2913736366core:WithinOneYear2023-11-2913736366core:AfterOneYear2023-11-2913736366core:ShareCapital2024-11-2913736366core:SharePremium2024-11-2913736366core:RevaluationReserve2024-11-2913736366core:OtherReservesSubtotal2024-11-2913736366core:RetainedEarningsAccumulatedLosses2024-11-2913736366core:ShareCapital2023-11-2913736366core:SharePremium2023-11-2913736366core:RevaluationReserve2023-11-2913736366core:OtherReservesSubtotal2023-11-2913736366core:RetainedEarningsAccumulatedLosses2023-11-2913736366core:LandBuildings2024-11-2913736366core:PlantMachinery2024-11-2913736366core:Vehicles2024-11-2913736366core:FurnitureFittings2024-11-2913736366core:OfficeEquipment2024-11-2913736366core:NetGoodwill2024-11-2913736366core:IntangibleAssetsOtherThanGoodwill2024-11-2913736366core:ListedExchangeTraded2024-11-2913736366core:UnlistedNon-exchangeTraded2024-11-2913736366core:LandBuildings2023-11-2913736366core:PlantMachinery2023-11-2913736366core:Vehicles2023-11-2913736366core:FurnitureFittings2023-11-2913736366core:OfficeEquipment2023-11-2913736366core:NetGoodwill2023-11-2913736366core:IntangibleAssetsOtherThanGoodwill2023-11-2913736366core:ListedExchangeTraded2023-11-2913736366core:UnlistedNon-exchangeTraded2023-11-2913736366core:LandBuildings2023-11-302024-11-2913736366core:PlantMachinery2023-11-302024-11-2913736366core:Vehicles2023-11-302024-11-2913736366core:FurnitureFittings2023-11-302024-11-2913736366core:OfficeEquipment2023-11-302024-11-2913736366core:NetGoodwill2023-11-302024-11-2913736366core:IntangibleAssetsOtherThanGoodwill2023-11-302024-11-2913736366core:ListedExchangeTraded2023-11-302024-11-2913736366core:UnlistedNon-exchangeTraded2023-11-302024-11-2913736366core:MoreThanFiveYears2023-11-302024-11-2913736366core:Non-currentFinancialInstruments2024-11-2913736366core:Non-currentFinancialInstruments2023-11-2913736366dpl:CostSales2023-11-302024-11-2913736366dpl:DistributionCosts2023-11-302024-11-2913736366core:LandBuildings2023-11-302024-11-2913736366core:PlantMachinery2023-11-302024-11-2913736366core:Vehicles2023-11-302024-11-2913736366core:FurnitureFittings2023-11-302024-11-2913736366core:OfficeEquipment2023-11-302024-11-2913736366dpl:AdministrativeExpenses2023-11-302024-11-2913736366core:NetGoodwill2023-11-302024-11-2913736366core:IntangibleAssetsOtherThanGoodwill2023-11-302024-11-2913736366dpl:GroupUndertakings2023-11-302024-11-2913736366dpl:ParticipatingInterests2023-11-302024-11-2913736366dpl:GroupUndertakingscore:ListedExchangeTraded2023-11-302024-11-2913736366core:ListedExchangeTraded2023-11-302024-11-2913736366dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-11-302024-11-2913736366core:UnlistedNon-exchangeTraded2023-11-302024-11-2913736366dpl:CostSales2022-11-302023-11-2913736366dpl:DistributionCosts2022-11-302023-11-2913736366core:LandBuildings2022-11-302023-11-2913736366core:PlantMachinery2022-11-302023-11-2913736366core:Vehicles2022-11-302023-11-2913736366core:FurnitureFittings2022-11-302023-11-2913736366core:OfficeEquipment2022-11-302023-11-2913736366dpl:AdministrativeExpenses2022-11-302023-11-2913736366core:NetGoodwill2022-11-302023-11-2913736366core:IntangibleAssetsOtherThanGoodwill2022-11-302023-11-2913736366dpl:GroupUndertakings2022-11-302023-11-2913736366dpl:ParticipatingInterests2022-11-302023-11-2913736366dpl:GroupUndertakingscore:ListedExchangeTraded2022-11-302023-11-2913736366core:ListedExchangeTraded2022-11-302023-11-2913736366dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-11-302023-11-2913736366core:UnlistedNon-exchangeTraded2022-11-302023-11-2913736366core:NetGoodwill2024-11-2913736366core:IntangibleAssetsOtherThanGoodwill2024-11-2913736366core:LandBuildings2024-11-2913736366core:PlantMachinery2024-11-2913736366core:Vehicles2024-11-2913736366core:FurnitureFittings2024-11-2913736366core:OfficeEquipment2024-11-2913736366core:AfterOneYear2024-11-2913736366core:WithinOneYear2024-11-2913736366core:ListedExchangeTraded2024-11-2913736366core:UnlistedNon-exchangeTraded2024-11-2913736366core:ShareCapital2024-11-2913736366core:SharePremium2024-11-2913736366core:RevaluationReserve2024-11-2913736366core:OtherReservesSubtotal2024-11-2913736366core:RetainedEarningsAccumulatedLosses2024-11-2913736366core:NetGoodwill2023-11-2913736366core:IntangibleAssetsOtherThanGoodwill2023-11-2913736366core:LandBuildings2023-11-2913736366core:PlantMachinery2023-11-2913736366core:Vehicles2023-11-2913736366core:FurnitureFittings2023-11-2913736366core:OfficeEquipment2023-11-2913736366core:AfterOneYear2023-11-2913736366core:WithinOneYear2023-11-2913736366core:ListedExchangeTraded2023-11-2913736366core:UnlistedNon-exchangeTraded2023-11-2913736366core:ShareCapital2023-11-2913736366core:SharePremium2023-11-2913736366core:RevaluationReserve2023-11-2913736366core:OtherReservesSubtotal2023-11-2913736366core:RetainedEarningsAccumulatedLosses2023-11-2913736366core:NetGoodwill2022-11-2913736366core:IntangibleAssetsOtherThanGoodwill2022-11-2913736366core:LandBuildings2022-11-2913736366core:PlantMachinery2022-11-2913736366core:Vehicles2022-11-2913736366core:FurnitureFittings2022-11-2913736366core:OfficeEquipment2022-11-2913736366core:AfterOneYear2022-11-2913736366core:WithinOneYear2022-11-2913736366core:ListedExchangeTraded2022-11-2913736366core:UnlistedNon-exchangeTraded2022-11-2913736366core:ShareCapital2022-11-2913736366core:SharePremium2022-11-2913736366core:RevaluationReserve2022-11-2913736366core:OtherReservesSubtotal2022-11-2913736366core:RetainedEarningsAccumulatedLosses2022-11-2913736366core:AfterOneYear2023-11-302024-11-2913736366core:WithinOneYear2023-11-302024-11-2913736366core:Non-currentFinancialInstrumentscore:CostValuation2023-11-302024-11-2913736366core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-302024-11-2913736366core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-302024-11-2913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-302024-11-2913736366core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-302024-11-2913736366core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-302024-11-2913736366core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-302024-11-2913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-302024-11-2913736366core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-302024-11-2913736366core:Non-currentFinancialInstrumentscore:CostValuation2024-11-2913736366core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-2913736366core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-2913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-2913736366core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-2913736366core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-2913736366core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-2913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-2913736366core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-2913736366core:Non-currentFinancialInstrumentscore:CostValuation2023-11-2913736366core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-2913736366core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-2913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-2913736366core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-2913736366core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-2913736366core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-2913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-2913736366core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-2913736366bus:Director12023-11-302024-11-29

222 HEALTHCARE SERVICES LIMITED

Registered Number
13736366
(England and Wales)

Unaudited Financial Statements for the Year ended
29 November 2024

222 HEALTHCARE SERVICES LIMITED
Company Information
for the year from 30 November 2023 to 29 November 2024

Director

LARGE, Oliver Drury Helliwell, Dr

Registered Address

2nd Floor Grove House
55 Lowlands Road
Harrow
HA1 3AW

Registered Number

13736366 (England and Wales)
222 HEALTHCARE SERVICES LIMITED
Balance Sheet as at
29 November 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets3120137
Tangible assets47,9614,731
8,0814,868
Current assets
Stocks510,034450
Debtors66,1315,345
Cash at bank and on hand44,6958,855
60,86014,650
Creditors amounts falling due within one year7(39,503)(28,487)
Net current assets (liabilities)21,357(13,837)
Total assets less current liabilities29,438(8,969)
Provisions for liabilities8(1,513)(1,183)
Net assets27,925(10,152)
Capital and reserves
Called up share capital100100
Profit and loss account27,825(10,252)
Shareholders' funds27,925(10,152)
The financial statements were approved and authorised for issue by the Director on 27 August 2025, and are signed on its behalf by:
LARGE, Oliver Drury Helliwell, Dr
Director
Registered Company No. 13736366
222 HEALTHCARE SERVICES LIMITED
Notes to the Financial Statements
for the year ended 29 November 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery25
Office Equipment25
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20242023
Average number of employees during the year32
3.Intangible assets

Other

Total

££
Cost or valuation
At 30 November 23170170
At 29 November 24170170
Amortisation and impairment
At 30 November 233333
Charge for year1717
At 29 November 245050
Net book value
At 29 November 24120120
At 29 November 23137137
4.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 30 November 233,2752,6455,920
Additions3,1861,3964,582
At 29 November 246,4614,04110,502
Depreciation and impairment
At 30 November 232449451,189
Charge for year8554971,352
At 29 November 241,0991,4422,541
Net book value
At 29 November 245,3622,5997,961
At 29 November 233,0311,7004,731
5.Stocks

2024

2023

££
Raw materials and consumables10,034450
Total10,034450
6.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables1,5981,640
Other debtors459486
Prepayments and accrued income4,0743,219
Total6,1315,345
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
7.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables10,7455,546
Taxation and social security7,019-
Other creditors15,90818,861
Accrued liabilities and deferred income5,8314,080
Total39,50328,487
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
8.Provisions for liabilities

2024

2023

££
Net deferred tax liability (asset)1,5131,183
Total1,5131,183
9.Guarantees provided on behalf of directors
The director's current account balance of £12,507 (2023: £537) relates to the director.